Literature DB >> 6213318

Facts about injectable contraceptives: memorandum from a WHO meeting.

.   

Abstract

Keywords:  Animals, Laboratory; Bleeding; Breast Feeding; Cancer; Carbohydrate Metabolic Effects; Clinical Research; Congenital Abnormalities; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods; Diseases; Economic Factors; Family Planning; Fertility; Injectables; Medroxyprogesterone Acetate--side effects; Menstruation Disorders; Neoplasms; Norethindrone Enanthate--side effects; Norethindrone--side effects; Research And Development; Research Methodology; Signs And Symptoms; Technology; Use-effectiveness

Mesh:

Substances:

Year:  1982        PMID: 6213318      PMCID: PMC2535954     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  43 in total

1.  Factors affecting the duration of action of the injectable contraceptive norethisterone enanthate.

Authors:  K Fotherby
Journal:  Contracept Deliv Syst       Date:  1981-07

2.  [Prolonged use of medroxyprogesterone acetate for contraception].

Authors:  J Pena Delgado; M Aleman Herrera; A Baez Reyes
Journal:  Sem Med Mex       Date:  1981-06-26

3.  The effects of medroxyprogesterone acetate on carbohydrate metabolism: measurements of glucose, insulin, and growth hormone after twelve months' use.

Authors:  W N Spellacy; A G Mcleod; W C Buhi; S A Birk
Journal:  Fertil Steril       Date:  1972-04       Impact factor: 7.329

Review 4.  Some aspects of the interaction between natural and synthetic female sex hormones and the liver.

Authors:  H Adlercreutz; R Tenhunen
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

5.  The long-term use of injectable norethisterone enanthate as a contraceptive.

Authors:  S el-Mahgoub; M Karim
Journal:  Contraception       Date:  1972-01       Impact factor: 3.375

6.  Fibrinolytic activity of veins during use of depot medroxyprogesterone acetate as a contraceptive.

Authors:  B Astedt; S Jeppsson; M Pandolfi
Journal:  Fertil Steril       Date:  1972-07       Impact factor: 7.329

7.  Injected progestogen and lactation.

Authors:  M Karim; R Ammar; S el-Mahgoub; B el-Ganzoury; F Fikri; I Abdou
Journal:  Br Med J       Date:  1971-01-23

8.  Hyperplastic and inflammatory nodules in the canine mammary gland.

Authors:  A M Cameron; L J Faulkin
Journal:  J Natl Cancer Inst       Date:  1971-12       Impact factor: 13.506

9.  Liver function studies and progestagen contraception. Review of an intramuscularly administered contraceptive.

Authors:  C R García; E E Wallach
Journal:  Fertil Steril       Date:  1968 Mar-Apr       Impact factor: 7.329

10.  The effect of medroxyprogesterone acetate on adrenocortical function in children with precocious puberty.

Authors:  A Sadeghi-Nejad; S L Kaplan; M M Grumbach
Journal:  J Pediatr       Date:  1971-04       Impact factor: 4.406

View more
  2 in total

Review 1.  [Depot gestagens].

Authors:  H P Zahradnik
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 2.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.